Role of lipid polymorphism in pulmonary surfactant

被引:68
作者
Perkins, WR
Dause, RB
Parente, RA
Minchey, SR
Neuman, KC
Gruner, SM
Taraschi, TF
Janoff, AS
机构
[1] LIPOSOME CO INC, PRINCETON, NJ 08540 USA
[2] PRINCETON UNIV, DEPT PHYS, PRINCETON, NJ 08544 USA
[3] THOMAS JEFFERSON UNIV, DEPT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA
关键词
D O I
10.1126/science.273.5273.330
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The development of artificial surfactants for the treatment of respiratory distress syndrome (RDS) requires lipid systems that can spread rapidly from solution to the air-water interface, Because hydration-repulsion forces stabilize liposomal bilayers and oppose spreading, liposome systems that undergo geometric rearrangement from the bilayer (lamellar) phase to the hexagonal II (H-II) phase could hasten lipid transfer to the air-water interface through unstable transition intermediates. A liposome system containing dipalmitoylphosphatidylcholine was designed; the system is stable at 23 degrees C but undergoes transformation to the H-II phase as the temperature increases to 37 degrees C. The spreading of lipid from this system to the air-water interface was rapid at 37 degrees C but slow at 23 degrees C, When tested in vivo in a neonatal rabbit model, such systems elicited an onset of action equal to that of native human surfactant. These findings suggest that lipid polymorphic phase behavior may have a crucial role in the effective functioning of pulmonary surfactant.
引用
收藏
页码:330 / 332
页数:3
相关论文
共 40 条
[1]   CHANGES IN OXYGENATION AND HEART-RATE AFTER ADMINISTRATION OF ARTIFICIAL SURFACTANT (ALEC) TO PRETERM INFANTS [J].
AHLUWALIA, JS ;
MORLEY, CJ .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1995, 72 (02) :F121-F122
[2]  
AMIRKHANIAN JD, 1995, LUNG, V173, P243
[3]  
BARROW RE, 1979, J PHYSIOL-LONDON, V295, P217, DOI 10.1113/jphysiol.1979.sp012963
[4]   SQUEEZE-OUT FROM MIXED MONOLAYERS OF DIPALMITOYLPHOSPHATIDYLCHOLINE AND EGG PHOSPHATIDYLGLYCEROL [J].
BOONMAN, A ;
MACHIELS, FHJ ;
SNIK, AFM ;
EGBERTS, J .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1987, 120 (02) :456-468
[5]  
Bourbon J. R., 1991, PULMONARY SURFACTANT
[6]  
BOURBON JR, 1991, PULMONARY SURFACTANT, P257
[7]  
BOURBON JR, 1991, PULMONARY SURFACTANT, P143
[8]   ONE-YEAR FOLLOW-UP OF 89 INFANTS WITH BIRTH WEIGHTS OF 500 TO 749 GRAMS AND RESPIRATORY-DISTRESS SYNDROME RANDOMIZED TO 2 RESCUE DOSES OF SYNTHETIC SURFACTANT OR AIR PLACEBO [J].
CASIRO, O ;
BINGHAM, W ;
MACMURRAY, B ;
WHITFIELD, M ;
SAIGAL, S ;
VINCER, M ;
LONG, W ;
ALLEN, A ;
BARD, H ;
CHERNICK, V ;
FINER, N ;
MCMILLAN, D ;
PELIOWSKI, A ;
SANKARAN, K ;
SCHIFF, D ;
SHUKLA, A ;
SMYTH, J ;
WATTS, J ;
CASIRO, OG ;
MODDEMANN, D ;
ROBERTSON, C ;
SAUVE, R ;
VINCER, MJ .
JOURNAL OF PEDIATRICS, 1995, 126 (05) :S53-S60
[9]   SURFACE-ANALYSIS OF LIPID LAYERS AT AIR WATER INTERFACES [J].
CHUNG, JB ;
HANNEMANN, RE ;
FRANSES, EI .
LANGMUIR, 1990, 6 (11) :1647-1655
[10]  
CLEMENTS JA, 1977, AM REV RESPIR DIS, V115, P67